Arkolith/Insider Trading/RAPP/Form 4

Ceesay Abraham

Chief Executive Officer, DirectorRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Feb 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$320K
Net Open-Market Flow
-$320K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2026Sell(S)4K$29.05$103K559K
Feb 18, 2026Sell(S)2K$29.80$63K21K
Feb 18, 2026Sell(S)3K$29.04$87K23K
Feb 18, 2026Sell(S)2K$29.80$68K556K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-059886) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML